Christian Béchon
Director/Board Member presso CHECKPOINT THERAPEUTICS, INC.
Patrimonio netto: 66 580 $ in data 31/03/2024
Profilo
Christian Béchon currently works at CHB Consultants Ltd., as Chairman & Chief Executive Officer from 2018, France Biotech Association, as Director from 2014, and Checkpoint Therapeutics, Inc., as Independent Director from 2018.
Mr. Béchon also formerly worked at LFB Biotechnologies SASU, as Chairman & Chief Executive Officer from 2012 to 2017, Laboratoire Français du Fractionnement et des Biotechnologies, as Chairman, President & Chief Executive Officer from 2010 to 2012, Quantum Genomics SA, as Director, rEVO Biologics, Inc., as Independent Director from 2006 to 2015, and Centre National d'Etudes Spatiales EPIC, as General Secretary in 1995.
Mr. Béchon received his undergraduate degree from Sciences Po and undergraduate degree from École Centrale Paris.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
19/03/2024 | 32 478 ( 0.14% ) | 66 580 $ | 31/03/2024 |
Posizioni attive di Christian Béchon
Società | Posizione | Inizio |
---|---|---|
CHECKPOINT THERAPEUTICS, INC. | Director/Board Member | 16/10/2018 |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Director/Board Member | 12/06/2014 |
CHB Consultants Ltd. | Chief Executive Officer | 01/01/2018 |
Precedenti posizioni note di Christian Béchon
Società | Posizione | Fine |
---|---|---|
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Chief Executive Officer | 04/12/2017 |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Chief Executive Officer | 01/01/2017 |
Centre National d'Etudes Spatiales EPIC | Corporate Secretary | 01/06/1995 |
REVO BIOLOGICS INC | Director/Board Member | - |
QUANTUM GENOMICS | Director/Board Member | - |
Formazione di Christian Béchon
Sciences Po | Undergraduate Degree |
École Centrale Paris | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
QUANTUM GENOMICS | Health Technology |
Aziende private | 7 |
---|---|
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
Centre National d'Etudes Spatiales EPIC | Government |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
CHB Consultants Ltd. | |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
Checkpoint Therapeutics, Inc. |
- Borsa valori
- Insiders
- Christian Béchon